The NCCN guidelines now include MammaPrint for identifying HR+/HER2- early-stage breast cancer patients who may benefit from ...

New NCCN guidelines recognize the utility of MammaPrint for guiding anthracycline therapy selection in HR+/HER2- early-stage ...

World Cancer Day promotes awareness and patient-centered cancer care, marking the 25th anniversary of the Charter of Paris Against Cancer. The 'United by Unique' campaign highlights the individuality ...

The Viz Oncology Suite is a clinical decision support system that integrates seamlessly with the electronic health record to ...

NCCN Clinical Practice Guidelines in Oncology for the Prevention and Treatment of Cancer-Related Infections now recommend monoclonal antibodies for pre-exposure prophylaxis against COVID-19 in ...

During an Oncology Policy Summit hosted by the National Comprehensive Cancer Network, experts weighed in on whether medical technology is ready for its next big leap. "AI isn't the future of cancer ...

PLYMOUTH MEETING, PA [October 6, 2025] — Today, the National Comprehensive Cancer Network ® (NCCN ®)—a nonprofit responsible for globally utilized guidelines for cancer care—is sharing new NCCN ...

The National Comprehensive Cancer Network Oncology Research Program announces funding for research projects to advance treatment for people with stage four breast cancer. Approximately 10% of people ...

The National Comprehensive Cancer Network celebrated its 30th anniversary with a series of presentations on cancer care practice changes—in both treatment and administration—plus new research, and ...

The National Comprehensive Cancer Network Oncology Research Program awards funding to researchers from Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Experts at the National Comprehensive Cancer Network (NCCN) have now issued an updated ...